RESUMO
Effects of long-term bisphosphonate (BP) administration on the metabolism of healthy bone and the concomitant changes in imaging are unclear. Hence, we aimed to retrospectively investigate the effects of long-term BP administration on the intact parietal bone using the standardised uptake value (SUV) derived from single photon emission computed tomography (SPECT). We enrolled 29 patients who had odontogenic infection, osteoporosis, bone metastasis cancer, or rheumatoid arthritis, and classified them into BP-naïve: A (14 patients) and BP-treated: B, < 4 years (7 patients) and C, ≥ 4 years (8 patients) groups. We measured the maximum bilateral SUV (SUVmax) of the parietal bone using quantitative bone SPECT software. There were significant differences in the duration of BP administration and SUVmax of the parietal bone among the diseases (P < 0.0001 and P = 0.0086, respectively). There was a positive correlation between the duration of BP administration and SUVmax of the parietal bone (rs = 0.65, P = 0.0002). The SUVmax was significantly different between A and B (P = 0.02) and between A and C (P = 0.0024) groups. This is the first report on the correlation between long-term BP administration and the SUVmax of the parietal bone using the quantitative bone SPECT analysis.
Assuntos
Difosfonatos/farmacologia , Osso Parietal/efeitos dos fármacos , Osso Parietal/diagnóstico por imagem , Tomografia Computadorizada com Tomografia Computadorizada de Emissão de Fóton Único/métodos , Idoso , Idoso de 80 Anos ou mais , Artrite Reumatoide/diagnóstico por imagem , Pressão Sanguínea , Neoplasias Ósseas/diagnóstico por imagem , Estudos Transversais , Feminino , Humanos , Infecções/diagnóstico por imagem , Masculino , Pessoa de Meia-Idade , Metástase Neoplásica , Processo Odontoide/diagnóstico por imagem , Osteoporose/diagnóstico por imagem , Projetos Piloto , Cintilografia , Estudos Retrospectivos , TecnécioRESUMO
BACKGROUND: Ketamine is a widely used anesthetic in experimental medicine. We have also used ketamine for surgical interventions and imaging in rats and found significantly impaired ossification between identically performed experiments, which only differed in the number of anesthetic events. In order to investigate this phenomenon, we estimated the absorbed ionizing radiation and also studied whether ketamine administration has disadvantageous effect on bone cell viability. METHODS: Spongious bone chips and parietal bone disks were harvested from rats. Explants were incubated in stem cell media containing 0.02, 0.2 and 2 mM ketamine. After 3 days of incubation, tetrazolium-based spectrophotometric assay was performed to measure cell viability. Size-specific dose estimation was used to calculate ionizing radiation of computed tomography imaging. RESULTS: We found that ketamine supplementation with 0.2 mM slightly decreased cell viability, while 2 mM caused significant reduction both in the spongious and cortical explants. The cumulative ionizing radiation was found to be negligible compared to irradiation dosages used to impair ossification. CONCLUSIONS: We conclude that multiple ketamine administration was responsible for the diminished regenerative potential of bone tissue in the present experimental setup. For this reason, we suggest that ketamine anesthesia should be avoided in studies investigating bone regeneration.
Assuntos
Analgésicos/toxicidade , Ketamina/toxicidade , Osso Parietal/efeitos dos fármacos , Osso Parietal/patologia , Cicatrização/efeitos dos fármacos , Animais , Sobrevivência Celular/efeitos dos fármacos , Sobrevivência Celular/fisiologia , Células Cultivadas , Relação Dose-Resposta a Droga , Masculino , Ratos , Ratos Wistar , Cicatrização/fisiologiaRESUMO
BACKGROUND: Polyetheretherketone (PEEK) exhibits stable chemical properties, excellent biocompatibility, and rational mechanical properties that are similar to those of human cortical bone, but the lack of bioactivity impedes its clinical application. METHODS: In this study, hydroxyapatite (HA) was incorporated into PEEK to fabricate HA/PEEK biocomposite using a compounding and injection-molding technique. The tensile properties of the prepared HA/PEEK composites (HA content from 0 to 40 wt%) were tested to choose an optimal HA content. To evaluate the bioactivity of the composite, the cell attachment, proliferation, spreading and alkaline phosphatase (ALP) activity of MC3T3-E1 cells, and apatite formation after immersion in simulated body fluid (SBF), and osseointegration in a rabbit cranial defect model were investigated. The results were compared to those from ultra-high molecular weight polyethylene (UHMWPE) and pure PEEK. RESULTS: By evaluating the tensile properties and elastic moduli of PEEK composite samples/PEEK composites with different HA contents, the 30 wt% HA/PEEK composite was chosen for use in the subsequent tests. The results of the cell tests demonstrated that PEEK composite samples/PEEK composite exhibited better cell attachment, proliferation, spreading, and higher ALP activity than those of UHMWPE and pure PEEK. Apatite islands formed on the HA/PEEK composite after immersion in SBF for 7 days and grew continuously with longer time periods. Animal tests indicated that bone contact and new bone formation around the HA/PEEK composite were more obvious than those around UHMWPE and pure PEEK. CONCLUSIONS: The HA/PEEK biocomposite created by a compounding and injection-molding technique exhibited enhanced osteogenesis and could be used as a candidate of orthopedic implants.
Assuntos
Materiais Biocompatíveis/administração & dosagem , Durapatita/administração & dosagem , Cetonas/administração & dosagem , Osso Parietal/efeitos dos fármacos , Polietilenoglicóis/administração & dosagem , Resistência à Tração/efeitos dos fármacos , Animais , Benzofenonas , Linhagem Celular , Avaliação Pré-Clínica de Medicamentos/métodos , Feminino , Osso Parietal/lesões , Osso Parietal/cirurgia , Polímeros , Coelhos , Resistência à Tração/fisiologiaRESUMO
BACKGROUND: Osteoinduction and subsequent bone formation rely on efficient mesenchymal stem cell (MSC) recruitment. It is also known that migration is induced by gradients of growth factors and cytokines. Degradation of Ca2+-containing biomaterials mimics the bone remodeling compartment producing a localized calcium-rich osteoinductive microenvironment. The aim of our study was to determine the effect of calcium sulfate (CaSO4) on MSC migration. In addition, to evaluate the influence of CaSO4 on MSC differentiation and the potential molecular mechanisms involved. METHODS: A circular calvarial bone defect (5 mm diameter) was created in the parietal bone of 35 Balb-C mice. We prepared and implanted a cell-free agarose/gelatin scaffold alone or in combination with different CaSO4 concentrations into the bone defects. After 7 weeks, we determined the new bone regenerated by micro-CT and histological analysis. In vitro, we evaluated the CaSO4 effects on MSC migration by both wound healing and agarose spot assays. Osteoblastic gene expression after BMP-2 and CaSO4 treatment was also evaluated by qPCR. RESULTS: CaSO4 increased MSC migration and bone formation in a concentration-dependent manner. Micro-CT analysis showed that the addition of CaSO4 significantly enhanced bone regeneration compared to the scaffold alone. The histological evaluation confirmed an increased number of endogenous cells recruited into the cell-free CaSO4-containing scaffolds. Furthermore, MSC migration in vitro and active AKT levels were attenuated when CaSO4 and BMP-2 were in combination. Addition of LY294002 and Wortmannin abrogated the CaSO4 effects on MSC migration. CONCLUSIONS: Specific CaSO4 concentrations induce bone regeneration of calvarial defects in part by acting on the host's undifferentiated MSCs and promoting their migration. Progenitor cell recruitment is followed by a gradual increment in osteoblast gene expression. Moreover, CaSO4 regulates BMP-2-induced MSC migration by differentially activating the PI3K/AKT pathway. Altogether, these results suggest that CaSO4 scaffolds could have potential applications for bone regeneration.
Assuntos
Regeneração Óssea/efeitos dos fármacos , Sulfato de Cálcio/farmacologia , Células-Tronco Mesenquimais/efeitos dos fármacos , Osteoblastos/efeitos dos fármacos , Osso Parietal/efeitos dos fármacos , Alicerces Teciduais , Androstadienos/farmacologia , Animais , Proteína Morfogenética Óssea 2/farmacologia , Diferenciação Celular , Movimento Celular/efeitos dos fármacos , Cromonas/farmacologia , Gelatina/química , Regulação da Expressão Gênica , Masculino , Células-Tronco Mesenquimais/citologia , Células-Tronco Mesenquimais/metabolismo , Camundongos , Camundongos Endogâmicos BALB C , Morfolinas/farmacologia , Osteoblastos/citologia , Osteoblastos/metabolismo , Osteogênese/efeitos dos fármacos , Osso Parietal/lesões , Osso Parietal/metabolismo , Fosfatidilinositol 3-Quinases/genética , Fosfatidilinositol 3-Quinases/metabolismo , Cultura Primária de Células , Proteínas Proto-Oncogênicas c-akt/genética , Proteínas Proto-Oncogênicas c-akt/metabolismo , Sefarose/química , Engenharia Tecidual , WortmaninaRESUMO
Hyaluronic acid (HA) filler injection is widely used for soft-tissue augmentation. Complications associated with HA filling are not uncommon; however, HA-induced alopecia is a rarely reported complication that could result in severe secondary psychological trauma. The etiology, clinical traits, treatment strategies, outcomes, and possible reversibility of HA-induced alopecia have not been characterized. Here, we report a case in which bilateral temple injections of 6.5 mL of HA led to persistent pain over the left scalp for several days. Although the pain was relieved at day 9 after 600 U of hyaluronidase were injected in the left temple, the patient developed localized alopecia at the left temporoparietal region with central skin necrosis at day 15. After topical applications of recombinant bovine basic fibroblast growth factor gel and 2% minoxidil spay, the necrotic skin wound was healed at day 42. Hair regrowth and normal hair density were restored at day 74. Analyses of Doppler ultrasound examinations and histopathology of the skin biopsy suggested that mild ischemia of the left temporoparietal region led to reversible alopecia, while the permanent hair loss in the left parietal area was associated with severe skin ischemia. Therefore, the key to treatment would be to focus on the effective correction of severe ischemia-induced skin necrosis to prevent permanent hair loss. Level of Evidence V This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Assuntos
Alopecia/induzido quimicamente , Arteriopatias Oclusivas/induzido quimicamente , Preenchedores Dérmicos/efeitos adversos , Cabelo/crescimento & desenvolvimento , Ácido Hialurônico/efeitos adversos , Osso Parietal/irrigação sanguínea , Couro Cabeludo/patologia , Adulto , Alopecia/diagnóstico por imagem , Alopecia/patologia , Arteriopatias Oclusivas/patologia , Artérias/patologia , Biópsia por Agulha , Técnicas Cosméticas/efeitos adversos , Preenchedores Dérmicos/farmacologia , Feminino , Seguimentos , Humanos , Ácido Hialurônico/administração & dosagem , Imuno-Histoquímica , Minoxidil/uso terapêutico , Necrose/etiologia , Necrose/patologia , Osso Parietal/efeitos dos fármacos , Recuperação de Função Fisiológica , Couro Cabeludo/irrigação sanguínea , Couro Cabeludo/efeitos dos fármacos , Ultrassonografia Doppler em Cores/métodosRESUMO
OBJECTIVE: The aim of this study is to analyze histologically the effect of CAPE on bone healing of Critical Size Defect (CSD) in rat calvaria. STUDY DESIGN: Thirty-two 3-month-old male rats were used. The animals were randomly divided into four groups. Group A received isotonic saline solution, Group B received CAPE (50 mmol/kg) locally, Group C received CAPE (100 mmol/kg) locally and Group D received CAPE (10 mmol/kg/day i.p. for 28 days) systematically. A 5-mm diameter calvarial defect was created in the right side of the parietal bone without damaging the underlying dura mater. Twenty-eight days after the surgery, all the animals were sacrificed. The original defect area was removed from the animal's calvarium bone en bloc. Beginning at the center of the surgical defect, serial sections of 6 µm thick were cut longitudinally. The sections were stained with hematoxylin and eosin for analysis under a light microscope. The sections were analyzed for the presence of inflammatory infiltrate, connective tissue formation and new bone formation. Computer-assisted histomorphometic measurements were carried out with an automated image analysis system. RESULTS: The total new bone areas were significantly greater in group D than in all groups and group C was statistically insignificant from the other groups (p < 0.05). Group B had a greater, but not statistically significant (p > 0.05), amount of total regenerated bone area than the control group. CONCLUSION: The results indicate that 100 mmol/kg topical and 10 mmol/kg/day systemic application of CAPE increases bone healing, especially with systemic application.
Assuntos
Antioxidantes/uso terapêutico , Doenças Ósseas/tratamento farmacológico , Ácidos Cafeicos/uso terapêutico , NF-kappa B/antagonistas & inibidores , Osteogênese/efeitos dos fármacos , Osso Parietal/efeitos dos fármacos , Álcool Feniletílico/análogos & derivados , Administração Tópica , Animais , Antioxidantes/administração & dosagem , Doenças Ósseas/patologia , Regeneração Óssea/efeitos dos fármacos , Ácidos Cafeicos/administração & dosagem , Tecido Conjuntivo/efeitos dos fármacos , Tecido Conjuntivo/patologia , Processamento de Imagem Assistida por Computador/métodos , Injeções Intraperitoneais , Masculino , Osso Parietal/patologia , Álcool Feniletílico/administração & dosagem , Álcool Feniletílico/uso terapêutico , Distribuição Aleatória , Ratos , Ratos Wistar , Cicatrização/efeitos dos fármacosRESUMO
BACKGROUND: Application of recombinant human bone morphogenetic protein-2 (rhBMP-2) has been associated with significant adverse events in craniofacial settings, including swelling and seroma formation. Recent work has demonstrated an inverse relationship between bone formation/maturation and rhBMP-2 dose, frequency/severity of adverse events increasing with rising dose. OBJECTIVE: The objective of this study was to determine the most effective dose for rhBMP-2 soak-loaded onto an absorbable collagen sponge (ACS) carrier for bone formation/maturation using an established defect model. METHODS: One hundred sixty-eight outbred male Sprague-Dawley rats, age 11-13 weeks, weight 325-375 g randomized into seven groups of 24 subdivided into groups of eight, were used to provide radiographic and light microscopy observations of bone formation/maturation and aberrant healing events at 2, 4 and 8 weeks following application of rhBMP-2/ACS into critical-size, ø8-mm, through-through, calvarial osteotomy defects for a dose of 1.25, 2.5, 5.0, 10.0 and 20.0 µg rhBMP-2/defect, or serve as ACS or sham-surgery controls. RESULTS: rhBMP-2 dosages ≥ 2.5 µg/defect showed histological defect closure >90% within 2 weeks, and complete resolution within 4 weeks. Adverse healing events including swelling, excessive bone formation or seroma formation could not be determined with certainty in this defect model. Notably ACS control sites showed complete defect closure at the 8-week healing interval. CONCLUSIONS: rhBMP-2/ACS accelerates local bone formation in the rat critical-size through-through calvarial defect model once reaching an osteoinductive dose threshold. This threshold may already be reached at a 1.25-/2.5-µg dose in this model. No further enhancement to bone formation/maturation may be observed adding rhBMP-2 above the 2.5-µg dose. The 1.25-20.0 µg dose range did not invoke appreciable aberrant healing events.
Assuntos
Doenças Ósseas/tratamento farmacológico , Proteína Morfogenética Óssea 2/uso terapêutico , Osteogênese/efeitos dos fármacos , Osso Parietal/efeitos dos fármacos , Fator de Crescimento Transformador beta/uso terapêutico , Implantes Absorvíveis , Animais , Densidade Óssea/efeitos dos fármacos , Medula Óssea/efeitos dos fármacos , Medula Óssea/patologia , Proteína Morfogenética Óssea 2/administração & dosagem , Calcificação Fisiológica/efeitos dos fármacos , Colágeno , Relação Dose-Resposta a Droga , Portadores de Fármacos , Masculino , Osso Parietal/patologia , Distribuição Aleatória , Ratos , Ratos Sprague-Dawley , Proteínas Recombinantes/administração & dosagem , Proteínas Recombinantes/uso terapêutico , Fatores de Tempo , Fator de Crescimento Transformador beta/administração & dosagem , Cicatrização/efeitos dos fármacosRESUMO
Particulate bone augmentation is an established clinical alternative to regenerate bone. However, in regions of poor bone quality or previously infected sites, the clinical outcomes are more inconsistent. For that purpose, peptides have been added to particulate materials in an attempt to render them with antibacterial properties or to improve their osseoconductivity. For instance, competence-stimulating peptide (CSP) has been studied to decrease the division rate of Streptococcus mutans. Also, the addition of a specific short amino acid sequence peptide derived from type I collagen (P-15) to the bone substitutes has been introduced in an attempt to increase its osseoconductivity. The present study hypothesized that xenogeneic graft materials with and without CSP would present improved host-to-biomaterial response when used in combination with P-15. Particulate graft materials with and without P-15, OsteoGraf with CSP and OsteoGraf, were implanted in an 8-mm rabbit calvarial defect for 4 weeks, and thereafter, histological and histomorphometrical evaluation was performed. The results showed that both OsteoGraf and CSP groups with the addition of P-15 induced bone growth towards the center of the defect. Furthermore, the addition of CSP to Osteograf showed a tendency to increase its osteoconductivity when combined with P-15. The results of the current study suggested that P-15 had some impact on osteogenesis; however, the effect differed between different bone substitute materials. Further investigation is necessary to clarify its effectiveness when used in combination with bone substitutes.
Assuntos
Substitutos Ósseos/uso terapêutico , Colágeno/uso terapêutico , Xenoenxertos/transplante , Fragmentos de Peptídeos/uso terapêutico , Animais , Proteínas de Bactérias/uso terapêutico , Doenças Ósseas/patologia , Doenças Ósseas/cirurgia , Regeneração Óssea/efeitos dos fármacos , Remodelação Óssea/efeitos dos fármacos , Transplante Ósseo/métodos , Bovinos , Competência de Transformação por DNA/fisiologia , Osteoblastos/efeitos dos fármacos , Osteoblastos/patologia , Osteogênese/efeitos dos fármacos , Osso Parietal/efeitos dos fármacos , Osso Parietal/patologia , Osso Parietal/cirurgia , CoelhosRESUMO
BACKGROUND: Autologous bone grafts are usually well consolidated after 4 to 5 months but can be incompletely interlocked with the native bone. This study investigated the effect of acid demineralization of the graft-bed interface on graft consolidation. METHODS: Onlay bone grafts were performed on the calvaria of 36 guinea pigs. Half of the animals had the graft-bed contacting surfaces demineralized with 50% citric acid (pH 1.0) for 3 minutes (test group). The other half received no demineralization (control group). The bone grafts were immobilized by a resorbable membrane glued to the recipient bed with cyanoacrylate. After 7, 30, and 90 days, specimens (n = 6) were obtained for light microscopy. Data from qualitative analysis and computerized histomorphometry were statistically processed at a significance level of 5%. RESULTS: Osteogenesis was not seen at the interface after 7 days. After 30 days, the test group showed 34.39% ± 13.4% of the interface area filled with mineralized tissue, compared to 17.14% ± 8.6% in the control group (P = 0.026). After 90 days, the mean percentages of mineralized tissue at the interface in the test and control specimens were 54.00% ± 11.23% and 38.65% ± 7.76% (P = 0.041), respectively. Within groups, a higher percentage of the area filled with mineralized tissue was seen at 90 days compared to 30 days (P = 0.004 for control and 0.041 for test). CONCLUSIONS: Demineralization of the contacting surfaces between autologous bone graft and bone bed improved new bone formation and bone consolidation. These data need to be confirmed in humans.
Assuntos
Autoenxertos/efeitos dos fármacos , Transplante Ósseo/métodos , Ácido Cítrico/uso terapêutico , Osteogênese/efeitos dos fármacos , Osso Parietal/efeitos dos fármacos , Implantes Absorvíveis , Animais , Autoenxertos/transplante , Técnica de Desmineralização Óssea , Matriz Óssea/efeitos dos fármacos , Matriz Óssea/patologia , Colágeno/química , Cianoacrilatos/efeitos adversos , Cianoacrilatos/uso terapêutico , Fibrina/análise , Tecido de Granulação/efeitos dos fármacos , Tecido de Granulação/patologia , Granuloma de Corpo Estranho/induzido quimicamente , Cobaias , Processamento de Imagem Assistida por Computador/métodos , Masculino , Membranas Artificiais , Osteócitos/efeitos dos fármacos , Osteócitos/patologia , Osso Parietal/transplante , Fatores de Tempo , Adesivos Teciduais/efeitos adversos , Adesivos Teciduais/uso terapêuticoRESUMO
BACKGROUND: Although enamel matrix derivative (EMD) has demonstrated the ability to promote angiogenesis and osteogenesis both in vitro and in vivo, the specific elements within the EMD compound responsible for these effects remain unknown. METHODS: Nine different protein pools from a commercially produced EMD were collected based on molecular weight. Six of these pools, along with the complete EMD unfractionated compound and positive and negative controls, were tested for their ability to induce bone formation in a calvarial induction assay. Immunocytochemistry of phosphorylated SMAD1/5/8 (phospho-SMAD), osterix, and vascular endothelial growth factor A (VEGF-A) was carried out at selected time points. Finally, proteomic analysis was completed to determine the specific protein-peptide content of the various osteoinductive pools. RESULTS: One of the lower-molecular-weight pools tested, pool 7, showed bone induction responses significantly greater than those of the other pools and the complete EMD compound and was concentration dependent. Dynamic bone formation rate analysis demonstrated that pool 7 was optimally active at the 5- to 10-µg concentration. It was demonstrated that EMD and pool 7 induced phospho-SMAD, osterix, and VEGF-A, which is indicative of increased bone morphogenetic protein (BMP) signaling. Proteomic composition analysis demonstrated that pool 7 had the highest concentration of the biologically active amelogenin-leucine-rich amelogenin peptide and ameloblastin 17-kDa peptides. CONCLUSIONS: These studies demonstrate that the low-molecular-weight protein pools (7 to 17 kDa) within EMD have greater osteoinductive potential than the commercially available complete EMD compound and that the mechanism of action, in part, is through increased BMP signaling and increased osterix and VEGF-A. With this information, selected components of EMD can now be formulated for optimal osteo- and angio-genesis.
Assuntos
Proteínas do Esmalte Dentário/análise , Amelogenina/análise , Animais , Proteínas Morfogenéticas Ósseas/efeitos dos fármacos , Cromatografia em Gel , Cromatografia Líquida de Alta Pressão , Proteínas do Esmalte Dentário/fisiologia , Relação Dose-Resposta a Droga , Eletroforese em Gel de Poliacrilamida , Espectrometria de Massas , Camundongos , Modelos Animais , Peso Molecular , Osteogênese/efeitos dos fármacos , Osso Parietal/efeitos dos fármacos , Periósteo/efeitos dos fármacos , Proteoma/análise , Proteína Smad1/análise , Proteína Smad1/farmacologia , Proteína Smad5/análise , Proteína Smad5/farmacologia , Proteína Smad8/análise , Proteína Smad8/farmacologia , Fator de Transcrição Sp7 , Fatores de Transcrição/análise , Fatores de Transcrição/farmacologia , Fator A de Crescimento do Endotélio Vascular/análise , Fator A de Crescimento do Endotélio Vascular/farmacologiaRESUMO
This study aims to analyze the effect of the low-level laser therapy (LLLT) and ozone therapy on the bone healing of critical size defect (CSD) in rat calvaria. A total of 30 Wistar male rats were used. A 5-mm-diameter trephine bur was used to create CSD on the right side of the parietal bone of each rat calvarium. Once the bone was excised, a synthetic biphasic calcium phosphate graft material was implanted to all the bone defect sites. The animals were randomly divided into 3 groups as follows: the control group (n = 10), which received no LLLT or ozone therapy; the LLLT group (n = 10), which received only LLLT (120 seconds, 3 times a week for 2 weeks); and the ozone therapy group (n = 10) (120 seconds, 3 times a week for 2 weeks). After 1 month, all the rats were killed, and the sections were examined to evaluate the presence of inflammatory infiltrate, connective tissue, and new bone formation areas. Histomorphometric analyses showed that in the LLLT and ozone groups, the new bone areas were significantly higher than in the control group (P < 0.05). In the LLLT group, higher new bone areas were found than in the ozone group (P < 0.05). This study demonstrated that both ozone and laser therapies had a positive effect on bone formation in rat calvarial defect, compared with the control group; however, ozone therapy was more effective than LLLT (808 nm; 0.1 W; 4 J/cm(2); 0.028 cm(2), continuous wave mode).
Assuntos
Regeneração Óssea , Terapia com Luz de Baixa Intensidade/métodos , Ozônio/uso terapêutico , Osso Parietal/lesões , Fraturas Cranianas/terapia , Animais , Regeneração Óssea/efeitos dos fármacos , Regeneração Óssea/efeitos da radiação , Substitutos Ósseos/uso terapêutico , Modelos Animais de Doenças , Masculino , Osso Parietal/efeitos dos fármacos , Osso Parietal/efeitos da radiação , Ratos , Ratos Wistar , Cicatrização/efeitos dos fármacos , Cicatrização/efeitos da radiaçãoRESUMO
The objective of this study was to valuate 2 substances as potential carriers of fibroblast growth factor 1 (FGF-1) in a rat craniectomy model: gelatin sponge (Spongostan; Ferrosan A/S, Søborg, Denmark) and natural bone mineral (Bio-Oss; Geistlich Biomaterials, Wolhusen, Switzerland).Forty-eight adult male Sprague-Dawley rats were used. A 5-mm-diameter circular craniectomy was performed in the left parietal bone. Animals were divided into 6 experimental groups of 8 rats, each group receiving a different treatment: control (no substance added), Spongostan, Bio-Oss, FGF, FGF + Spongostan, and FGF + Bio-Oss. Animals were killed 12 weeks after surgery.Descriptive histology and stereology were used, the latter to measure the volumes of regenerated bone and Bio-Oss remaining in the defect. Analysis of variance was used to determine differences in bone regeneration between groups, and Mann-Whitney U test was used to compare the volume of remaining Bio-Oss particles.Histologically, the control defects behaved like critical size defects, showing incomplete bone regeneration. Only the FGF + Spongostan group achieved nearly complete bone regeneration. Bio-Oss particles seemed to reduce centripetal bone regeneration. Spongostan by itself did not interfere with spontaneous bone healing.Stereologic measurements of the volume of new bone growth, measured in cubic millimeter, were as follows: control group, 3.86 ± 1.03; Bio-Oss, 2.26 ± 1.06; Spongostan, 3.00 ± 0.81; FGF, 3.99 ± 1.85; FGF + Bio-Oss, 3.02 ± 1.88; and FGF + Spongostan, 8.93 ± 1.28. Analysis of variance showed a statistically significant difference between the FGF + Spongostan group and the other groups (P < 0.001). Comparison among the other groups did not show significant differences.Fibroblast growth factor 1 with a Spongostan carrier has shown great efficacy for bone regeneration in cranial critical size defects in rats. Bio-Oss did not produce a regenerative effect, either alone or with FGF-1.
Assuntos
Doenças Ósseas/cirurgia , Regeneração Óssea/efeitos dos fármacos , Substitutos Ósseos/uso terapêutico , Espuma de Fibrina/uso terapêutico , Fator 1 de Crescimento de Fibroblastos/uso terapêutico , Minerais/uso terapêutico , Osso Parietal/cirurgia , Animais , Materiais Biocompatíveis/uso terapêutico , Portadores de Fármacos , Fator 1 de Crescimento de Fibroblastos/administração & dosagem , Masculino , Osteoclastos/patologia , Osso Parietal/efeitos dos fármacos , Osso Parietal/patologia , Distribuição Aleatória , Ratos , Ratos Sprague-Dawley , Fatores de Tempo , Cicatrização/efeitos dos fármacosRESUMO
BACKGROUND: Isotretinoin is a vitamin A derivative, indicated for the treatment of patients with severe acne, which shows several side effects on bone metabolism. OBJECTIVE: This study analyzed the process of bone repair in rats receiving 7.5 mg/kg/day of oral isotretinoin. METHODS: Thirty-three male albino Wistar rats, at approximately 60 days of age, were randomly assigned to control (n = 15) and experimental (n = 18) groups. Only the experimental group underwent oral isotretinoin therapy. In both groups, a 2-mm cavity was established in the calvarium of each animal. The animals were euthanize 21, 28 and 90 days postoperatively. The parietal bone was removed and the surgical specimens underwent histological examination. Computed histomorphometry allowed the measurement of the total area of bone defects and the proportion of newly formed bone at the different observation time points. RESULTS: In the experimental group, the results, expressed as mean percentage of newly formed bone, were: 25.37% (±9.14) at day 21; 41.78% (±7.00) at day 28; and 57.51% (±11.62) at day 90. In the control group, the results were: 17.10% (±9.23) at day 21; 34.42% (±7.70) at day 28; and 48.49% (±16.40) at day 90. CONCLUSION: These results enabled us to conclude that isotretinoin promoted acceleration in the process of new bone formation in rat calvaria, although this increase was not statistically significant.
Assuntos
Doenças Ósseas/tratamento farmacológico , Isotretinoína/uso terapêutico , Osso Parietal/efeitos dos fármacos , Administração Oral , Animais , Craniotomia/métodos , Processamento de Imagem Assistida por Computador/métodos , Isotretinoína/administração & dosagem , Masculino , Osteogênese/efeitos dos fármacos , Osso Parietal/patologia , Distribuição Aleatória , Ratos , Ratos Wistar , Fatores de Tempo , Cicatrização/efeitos dos fármacosRESUMO
BACKGROUND AND OBJECTIVES: The aim of this study was to compare culture-expanded, bone marrow-derived mesenchymal stem cells (MSCs) and platelet-rich plasma (PRP) loaded to biphasic calcium phosphate (BCP) bone ceramic in the repair of rat calvarial bone. MATERIALS AND METHODS: Critical-size (7 mm dia.) calvarial defects were prepared in the frontal-parietal bones of 90 adult female Sprague-Dawley rats. Rats were randomly divided into 5 groups, according to defect filling, as follows: Group I (n = 21), BCP; Group II (n = 21), BCP+PRP; Group III (n = 21), BCP+MSC; Group IV (n = 21), BCP+PRP+MSC; Group V (n = 6) (control), no treatment. Animals were sacrificed at 2, 8 and 12 weeks postsurgery and bone regeneration was evaluated both histologically and immunohistochemically. RESULTS: Statistically significant differences were observed in bone osteoblastic activity in calvarial defects among the groups (p < 0.05). PRP and MSC used in combination with BCP as a defect filling resulted in greater osteoblastic bone formation activity when compared to the use of BCP alone. CONCLUSIONS: The combination of mesenchymal stem cells, platelet rich plasma and synthetic bone substitute was found to be more effective in inducing new bone formation (osteogenesis) than the use of platelet rich plasma combined with synthetic bone substitute and the use of synthetic bone substitute alone.
Assuntos
Regeneração Óssea , Transplante de Células-Tronco Mesenquimais , Osteoblastos/transplante , Osso Parietal/cirurgia , Animais , Biomarcadores/metabolismo , Substitutos Ósseos/farmacologia , Células Cultivadas , Terapia Combinada , Feminino , Citometria de Fluxo , Hidroxiapatitas/farmacologia , Peptídeos e Proteínas de Sinalização Intercelular/sangue , Osteoblastos/efeitos dos fármacos , Osteoblastos/metabolismo , Osteoblastos/patologia , Osso Parietal/efeitos dos fármacos , Osso Parietal/metabolismo , Osso Parietal/patologia , Plasma Rico em Plaquetas , Ratos , Ratos Wistar , Fatores de TempoRESUMO
Skeletal bone losses are mainly filled with autologous graft or artificial materials. Osteoblasts are essential to maintain bone homeostasis and bone repair through a matrix synthesis. We have previously demonstrated that adherence and regenerative matrix composition are fundamental to bone healing, even in critical situations. In this work the critical size defect technique was used to evaluate the systemic activity on bone regeneration of a novel mixture of extracellular polysaccharides. A 5mm diameter hole was made in each parietal bone of male Wistar rats. The right parietal bone hole was filled with a mixture of hyaluronic acid, chondroitin 6 sulphate, and dermatan sulphate mixed with 2.5% NaCl solution, while the left hole was left free of material and untreated and considered as control. Twenty-one days after surgery, the holes and surrounding tissues were examined visually, using X-rays, and by histological staining. Using the matrix substitute, bone healing was almost complete after 21 days in the treated hole and always complete in the control side due to some systemic effect. Neovascularization was also observed along with organized trabecular bone on both sides. No abnormal bone growth or connective tissue abnormalities were noted. At the end of the experiment, 95.1% (± 3.2) bone healing (n=20) was observed on the treated side; conversely, healing bone and histological structure were better on the control side.
Assuntos
Materiais Biocompatíveis/uso terapêutico , Regeneração Óssea/efeitos dos fármacos , Sulfatos de Condroitina/uso terapêutico , Dermatan Sulfato/uso terapêutico , Ácido Hialurônico/uso terapêutico , Osso Parietal/efeitos dos fármacos , Animais , Doenças Ósseas/tratamento farmacológico , Modelos Animais de Doenças , Masculino , Neovascularização Fisiológica/efeitos dos fármacos , Osteogênese/efeitos dos fármacos , Osso Parietal/patologia , Periósteo/efeitos dos fármacos , Periósteo/patologia , Ratos , Ratos Wistar , Fatores de Tempo , Cicatrização/efeitos dos fármacosRESUMO
This study analyzed the newly formed bone tissue after application of recombinant human BMP-2 (rhBMP-2) and P-1 (extracted from Hevea brasiliensis) proteins, 2 weeks after the creation of a critical bone defect in male Wistar rats treated or not with a low-intensity laser (GaAlAs 780 nm, 60 mW of power, and energy density dose of 30 J/cm(2)). The animals were divided into two major groups: (1) bone defect plus low-intensity laser treatment and (2) bone defect without laser irradiation. The following subgroups were also analyzed: (a) 5 µg of pure rhBMP-2; (b) 5 µg of pure P-1 fraction; (c) 5 µg of rhBMP-2/monoolein gel; (d) 5 µg of P-1 fraction/monoolein gel; (e) pure monoolein gel. Comparisons of the groups receiving laser treatment with those that did not receive laser irradiation show differences in the areas of new bone tissue. The group treated with 5 µg of rhBMP-2 and laser irradiation was not significantly different (P >0.05) than the nonirradiated group that received the same treatment. The irradiated, rhBMP-2/monoolein gel treatment group showed a lower area of bone formation than the nonirradiated, rhBMP-2/gel monoolein treatment group (P < 0.001). The area of new bone tissue in the other nonirradiated and irradiated groups was not significantly different (P > 0.05). Furthermore, the group that received the 5 µg of rhBMP-2 application showed the greatest bone formation. We conclude that the laser treatment did not interfere with the area of new bone tissue growth and that the greatest stimulus for bone formation involved application of the rhBMP-2 protein.
Assuntos
Proteína Morfogenética Óssea 2/farmacologia , Hevea/química , Terapia com Luz de Baixa Intensidade , Osteogênese/efeitos dos fármacos , Osso Parietal/efeitos dos fármacos , Proteínas de Plantas/farmacologia , Fator de Crescimento Transformador beta/farmacologia , Animais , Proteína Morfogenética Óssea 2/administração & dosagem , Glicerídeos/administração & dosagem , Humanos , Imuno-Histoquímica , Masculino , Osteogênese/efeitos da radiação , Osso Parietal/lesões , Proteínas de Plantas/administração & dosagem , Ratos , Ratos Wistar , Proteínas Recombinantes/administração & dosagem , Proteínas Recombinantes/farmacologia , Fraturas Cranianas/tratamento farmacológico , Fraturas Cranianas/radioterapia , Fator de Crescimento Transformador beta/administração & dosagemRESUMO
This investigation examined the effects of pharmacologically induced precocious puberty on cranial growth in Wistar rats. Forty-eight female newborn Wistar rats were divided into two groups: a control group (C) and an experimental group (E), with four subgroups of six animals each. The time interval from birth until sacrifice differed between the subgroups, and was set at 30, 60, 90, and 120 days. An intramuscular single dose (300 µg) of steroid hormone danazol was administered on day 5 after birth, as a means of inducing precocious puberty. Alizarin (2 mg/100 g) was administered to three animals in each subgroup three days prior to sacrifice. Body mass and dates corresponding to the beginning of the oestrous cycle were recorded. Craniometric measurements were undertaken. Histological analysis using light and fluorescence microscopy was then carried out to qualitatively and quantitatively evaluate the spheno-occipital synchondrosis and to visualize bone deposition patterns. The results were analysed with a Student's t-test and analysis of variance. Precocious puberty was effectively induced and differences between groups denoted an earlier maturation in the experimental rats. In qualitative analysis, a significant increase of total synchondrosis width was noted only in group E60, in comparison with C60, and an increase in the E90 subgroup cortical bone width compared with the C90 subgroup. Histomorphometrically, a statistical difference between total width values of subgroups E60 (434.3 µm) and C60 (323.5 µm) was detected. However, body mass and macroscopic measurements did not show statistically significant differences. An appropriate model for studying bone growth associated with precocious puberty in Wistar female rats was not achieved using steroid hormone danazol, when evaluated at 30 day intervals.
Assuntos
Puberdade Precoce/fisiopatologia , Crânio/crescimento & desenvolvimento , Animais , Animais Recém-Nascidos , Antraquinonas , Composição Corporal/efeitos dos fármacos , Medula Óssea/efeitos dos fármacos , Medula Óssea/patologia , Calcificação Fisiológica/efeitos dos fármacos , Cartilagem/efeitos dos fármacos , Cartilagem/crescimento & desenvolvimento , Cefalometria/métodos , Condrócitos/efeitos dos fármacos , Condrócitos/patologia , Corantes , Suturas Cranianas/efeitos dos fármacos , Suturas Cranianas/crescimento & desenvolvimento , Danazol/efeitos adversos , Antagonistas de Estrogênios/efeitos adversos , Ciclo Estral/efeitos dos fármacos , Feminino , Microscopia de Fluorescência , Osso Nasal/efeitos dos fármacos , Osso Nasal/crescimento & desenvolvimento , Osso Occipital/efeitos dos fármacos , Osso Occipital/crescimento & desenvolvimento , Osso Parietal/efeitos dos fármacos , Osso Parietal/crescimento & desenvolvimento , Puberdade Precoce/induzido quimicamente , Ratos , Ratos Wistar , Crânio/efeitos dos fármacos , Osso Esfenoide/efeitos dos fármacos , Osso Esfenoide/crescimento & desenvolvimento , Fatores de TempoRESUMO
BACKGROUND: Recombinant human bone morphogenetic protein-2 (rhBMP-2) delivered on an absorbable collagen sponge is a U.S. Food and Drug Administration-approved therapy effective at generating bone formation. In pediatric patients for whom other therapeutic options have been exhausted, rhBMP-2 is used off-label to address problematic bony defects. In the skeletally immature patient, the safety of rhBMP-2 therapy remains uncertain. Experiments are needed that investigate the effect of rhBMP-2 on growth and development in clinically relevant models. METHODS: Ten juvenile rabbits underwent creation of a parietal skull defect that was treated with either 0.2 mg/cc rhBMP-2/absorbable collagen sponge or a neutral buffer solution/absorbable collagen sponge. Amalgam markers were placed at suture confluences to track suture separation and skull growth. Cranial growth was assessed radiographically at 10, 25, 42, and 84 days of age. Means and standard deviations for the various craniofacial growth variables were calculated and compared. Mean differences were considered significant for values of p < 0.05. At 84 days, sutures were analyzed by means of micro-computed tomographic scanning and histologic staining. RESULTS: Treatment with rhBMP-2 resulted in fusion of the coronal sutures bilaterally, with variable fusion of the sagittal suture by cephalometric, radiographic, and histologic analysis. There were statistically significant changes to coronal suture growth, sagittal suture growth, skull height, craniofacial length, and intracranial volume (p < 0.05). CONCLUSIONS: The use of rhBMP-2 in this juvenile animal model resulted in skeletal changes that may be undesirable in a clinical setting. The appearance of these fused sutures suggested a direct effect of rhBMP-2. Further work is required to limit the effect of rhBMP-2 to the target defect when used in the immature skeleton.
Assuntos
Proteínas Morfogenéticas Ósseas/efeitos adversos , Regeneração Óssea/efeitos dos fármacos , Craniossinostoses/induzido quimicamente , Osteogênese/efeitos dos fármacos , Proteínas Recombinantes/efeitos adversos , Fator de Crescimento Transformador beta/efeitos adversos , Animais , Proteína Morfogenética Óssea 2 , Craniossinostoses/patologia , Modelos Animais de Doenças , Esponja de Gelatina Absorvível , Humanos , Osso Parietal/efeitos dos fármacos , Osso Parietal/crescimento & desenvolvimento , CoelhosRESUMO
OBJECTIVE: This study compared the healing of 2 laser ablation units, erbium YAG and femtosecond lasers versus conventional mechanical cutting with carbide and diamond drills to explore future applications for bone surgery. The effects of laser or mechanical ablation combined with rhBMP-7 were also investigated. METHODS AND MATERIALS: Following defect standardization, a full-thickness circular defect was created on the parietal bones of 160 mice divided into 4 groups: carbide drill, diamond drill, erbium YAG laser, and femtosecond laser. Each of the 4 ablation groups was treated with and without BMP 7. Hard tissue healing was assessed using microcomputerized tomography at 3 and 12 weeks postsurgical time points. RESULTS: The femtosecond laser created wounds that showed slightly delayed bone healing during the observation period when compared with mechanical drilling, although the difference was not statistically significant. The Er:YAG laser showed a healing rate similar to that of the mechanically ablated groups. When BMP 7 was added to the surgical sites, bone wound closure occurred at a similar rate in all test groups. CONCLUSIONS: The femtosecond and Er:YAG lasers are 2 laser modalities suitable for bone ablation that are comparable to mechanical instrumentation in terms of bone healing. This study suggested that BMP-7 may be used to enhance bone healing with success regardless of the ablative modality used, whether laser or mechanical drilling.
Assuntos
Proteína Morfogenética Óssea 7/uso terapêutico , Craniotomia/instrumentação , Terapia a Laser/instrumentação , Lasers de Estado Sólido/uso terapêutico , Lasers/classificação , Osso Parietal/cirurgia , Animais , Carbono , Diamante , Desenho de Equipamento , Feminino , Processamento de Imagem Assistida por Computador/métodos , Imageamento Tridimensional/métodos , Camundongos , Camundongos Endogâmicos ICR , Osso Parietal/efeitos dos fármacos , Osso Parietal/patologia , Fatores de Tempo , Cicatrização/efeitos dos fármacos , Cicatrização/fisiologia , Microtomografia por Raio-X/métodosRESUMO
Suture expansion osteogenesis, which induces active bone formation within the distracted area by mechanical stress, provides an alternative form of treatment of some bone deficiency problems in craniofacial field, such as craniosynostosis, palate cleft, or narrow maxilla. However, how to stimulate new bone formation within the distracted area remains a great challenge. In this study, the effect of recombinant human bone morphogenetic protein (rhBMP-4) on bone formation induced by mechanical stimuli was investigated. The expanded midsagittal sutures of the rat calvaria were maintained in an organ culture system in the absence (control group) or presence (experimental group) of rhBMP-4 (25 or 50 ng/mL). Proliferating cell nuclear antigen, alkaline phosphatase (ALP) activity, and messenger RNA levels of core-binding factor alpha 1 (Cbfa1) and ALP were detected to determine the cell proliferation and differentiation. Bone formation within the suture was evaluated by histologic and fluorescent examination. No difference in the number of proliferating cell nuclear antigen-positive cells was found between the control and the experimental groups, whereas ALPase activity and messenger RNA levels of Cbfa1 and ALP in the experimental group were higher than that in the control group. Bone formation was accelerated in the rhBMP-4-treated group when compared with the control group. In addition, the amounts of bone formation and cell differentiation in response to 25 ng/mL of rhBMP-4 were almost equal to those induced by 50 ng/mL of rhBMP-4. Our results suggest that application of exogenous rhBMP-4 could enhance new bone formation within the rapid expanded sutures by stimulating osteoblast differentiation.